Actively Recruiting

Age: 18Months +
All Genders
Healthy Volunteers
NCT02461446

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

Led by Boston Children's Hospital · Updated on 2024-10-26

170

Participants Needed

5

Research Sites

604 weeks

Total Duration

On this page

Sponsors

B

Boston Children's Hospital

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.

CONDITIONS

Official Title

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

Who Can Participate

Age: 18Months +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals aged 18 months and older at the time of consent with a clinical diagnosis of autism spectrum disorder and/or a verified PTEN mutation
  • Macrocephaly defined as head circumference greater than or equal to the 98th percentile for inclusion in the ASD macrocephaly group
  • Consent from parents or legal guardian for youths; consent from self or legal guardian for adults
  • Assent from youths able to provide it according to IRB guidelines
  • Families may enroll multiple children meeting the criteria, with separate consent for each
  • Primary communicative language must be English
Not Eligible

You will not qualify if you...

  • Unwilling or unable to comply with study procedures and assessments
  • Presence of clinically significant medical disease that would prevent participation
  • Contraindications to 3T MRI scanning for those eligible for imaging biomarker assessment, including metal implants or incompatible medical devices such as vagus nerve stimulators
  • Contraindications to EEG/ERP biomarker assessment including uncooperative or destructive behaviors preventing lead placement or data capture
  • Age under 2 or over 11 years at enrollment for participants eligible for EEG/ERP assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

University of California at Los Angeles

Los Angeles, California, United States, 90095

Actively Recruiting

2

Stanford University Medical Center

Stanford, California, United States, 94305

Actively Recruiting

3

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

5

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

R

Rajna Filip-Dhima, MS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here